ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 900

Deletion of RBP-J in a Murine Model of Inflammatory Arthritis Reveals Differential Pro-Inflammatory Cytokine and FoxP3 Gene Expression

Soumya D. Chakravarty1, Karmen Au2, Xiaoyu Hu3 and Lionel B. Ivashkiv4, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Arthritis Tissue Degeneration Program, Hospital for Special Surgery, New York, NY, 4Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cytokines, inflammatory arthritis and regulatory cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, and Gene Regulation

Session Type: Abstract Submissions (ACR)

Background/Purpose: The DNA-binding protein RBP-J serves as the central transcriptional regulator of the Notch signaling pathway. Prior work done using a knockdown approach of RBP-J in human macrophages and conditional deletion of RBP-J in mouse macrophages has demonstrated diminished LPS-induced expression of TNFa, IL-6 and IL-12p40, with IL-1 induction preserved. Elsewhere, it has been observed that host regulatory T cells in RBP-J deficient mice have an attenuated ability to suppress effector T cell responses in vitro, with augmented proliferation and function of effector T cells noted in vivo, raising the possibility that dysregulation in the frequency or function of regulatory T cells may contribute to RBP-J’s selective modulation of pro-inflammatory mediators. Here, we evaluated the in vivo effects of RBP-J’s conditional deletion in the myeloid cell compartment on pro-inflammatory cytokine expression, as well as lymphoid tissue immunocyte composition, using a K/BxN serum transfer model of inflammatory arthritis.

Methods: RBP-Jflox/flox LysM-Cre knock-out (KO) mice with littermate RBP-J+/+LysM-Cre controls (n=5 for each group) were used. After treatment with K/BxN serum, the clinical course of arthritis was followed by measuring total joint thickness up to 14 days, at which point the mice were sacrificed. Total joint RNA from each mouse was obtained for gene expression analyses by qPCR. Splenic tissue was harvested from each mouse for gene expression analyses by qPCR, as well as pooled collectively for each group for immunophenotyping through flow cytometry. The latter was also done for superficial inguinal and draining popliteal lymph node (LN) tissue. Statistical analysis was done using the unpaired student’s t-test with p < 0.05 considered significant.

Results: Preliminary findings showed no significant difference in clinical phenotype of K/BxN serum-induced arthritis between KO and control mice. Gene expression profiling of whole joint tissue showed decreases in TNFa, IL-6, IFN-g expression, as well as selective Notch target gene expression, while maintaining comparable IL-1, CXCL10, and IL-12p40 levels. Surprisingly, expression levels of FoxP3 in KO mice vs. controls were significantly decreased in both joint and splenic tissue (p=0.0244 and p=0.0286, respectively). Immunophenotyping of splenic and LN tissue showed increased proportions of total CD4+ T cells in KO mice vs. controls, but a markedly lower proportion of the CD4+CD25+FoxP3+ subset. Lower proportions of F4/80+ and Ly6G+ cell populations in splenic and draining LN tissue of KO mice vs controls, but higher populations of Ly6C+ cells, were also observed.

Conclusion: Deletion of RBP-J in the myeloid compartment does not lead to phenotypic differences in K/BxN serum-induced inflammatory arthritis, though selective modulation of pro-inflammatory cytokine gene expression in vivo does occur. Decreased gene expression of FoxP3 and fewer CD4+CD25+FoxP3+ cells in RBP-J deleted mice may contribute to this selective modulation. The functional significance of these findings, coupled with differences in myeloid cell composition and trafficking observed, remain undetermined and will be further studied.


Disclosure:

S. D. Chakravarty,
None;

K. Au,
None;

X. Hu,
None;

L. B. Ivashkiv,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/deletion-of-rbp-j-in-a-murine-model-of-inflammatory-arthritis-reveals-differential-pro-inflammatory-cytokine-and-foxp3-gene-expression/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology